Background: Increased levels of tumor necrosis factor (TNF)-alpha and oxidative stress have been implicated as factors contributing to hepatic injury in fatty liver diseases. As steatosis is associated with an accelerated progression of fibrosis in chronic hepatitis C (HCV), we hypothesized that the messenger (m)RNA expression of genes involved with the production of reactive oxygen species, inflammation and cellular injury would be increased in liver tissue from subjects with steatosis and chronic HCV. Methods: Real-time polymerase chain reaction was performed to determine relative mRNA expression levels of collagen I, TNF-alpha, cytochrome P450 2E1 (CYP 2E1), transforming growth factor-beta1 and CD14 in liver biopsies from 38 patients wit...
Objective: To assess the presence of steatosis and other histological changes in patients with chron...
Chronic liver disease (CLD) is associated with tissue-destructive fibrosis. Considering that common ...
Hepatic steatosis is commonly seen in patients with chronic hepatitis C infection, and the two toget...
Obesity and fatty liver are commonly observed among patients with chronic hepatitis C virus (HCV) an...
The role of steatosis in the progression of liver damage in chronic hepatitis C (CHC) was studied. E...
BACKGROUND & AIMS: Steatosis is a frequent histologic finding in chronic hepatitis C (CHC), but ...
BACKGROUND/AIMS: The contribution of oxidative stress to the pathogenesis of chronic hepatitis C (CH...
Background/Aims: Steatosis is a frequent histological finding in chronic hepatitis C and is associat...
To gain insight into pathogenic mechanisms underlying fibrosis in hepatitis C virus (HCV)-mediated l...
he contribution of oxidative stress to the pathogenesis of chronic hepatitis C (CHC) is still poorl...
BACKGROUND/AIM: Both steatosis and insulin resistance have been linked to accelerated fibrosis in ch...
Background: Hepatic steatosis and disturbances in lipid metabolism has been identified as one of the...
Abstract: Aim: To assess whether a correlation exists between oxidative DNA damage occurring in chro...
Abstract: INTRODUCTION: Transforming growth factor beta 1 (TGFB1) and platelet-derived growth fact...
AIM: We aimed study impact of hepatocytic viral load, steatosis, and iron load on fibrosis in chroni...
Objective: To assess the presence of steatosis and other histological changes in patients with chron...
Chronic liver disease (CLD) is associated with tissue-destructive fibrosis. Considering that common ...
Hepatic steatosis is commonly seen in patients with chronic hepatitis C infection, and the two toget...
Obesity and fatty liver are commonly observed among patients with chronic hepatitis C virus (HCV) an...
The role of steatosis in the progression of liver damage in chronic hepatitis C (CHC) was studied. E...
BACKGROUND & AIMS: Steatosis is a frequent histologic finding in chronic hepatitis C (CHC), but ...
BACKGROUND/AIMS: The contribution of oxidative stress to the pathogenesis of chronic hepatitis C (CH...
Background/Aims: Steatosis is a frequent histological finding in chronic hepatitis C and is associat...
To gain insight into pathogenic mechanisms underlying fibrosis in hepatitis C virus (HCV)-mediated l...
he contribution of oxidative stress to the pathogenesis of chronic hepatitis C (CHC) is still poorl...
BACKGROUND/AIM: Both steatosis and insulin resistance have been linked to accelerated fibrosis in ch...
Background: Hepatic steatosis and disturbances in lipid metabolism has been identified as one of the...
Abstract: Aim: To assess whether a correlation exists between oxidative DNA damage occurring in chro...
Abstract: INTRODUCTION: Transforming growth factor beta 1 (TGFB1) and platelet-derived growth fact...
AIM: We aimed study impact of hepatocytic viral load, steatosis, and iron load on fibrosis in chroni...
Objective: To assess the presence of steatosis and other histological changes in patients with chron...
Chronic liver disease (CLD) is associated with tissue-destructive fibrosis. Considering that common ...
Hepatic steatosis is commonly seen in patients with chronic hepatitis C infection, and the two toget...